{"id":["dat.dogliotti2014"],"title":["Studies on Antithrombotic Treatments to Prevent Strokes"],"display_title":[""],"description":["Results from 20 trials examining the effectiveness ofantithrombotic treatments to prevent strokes in patients withnon-valvular atrial fibrillation."],"details":["This data set comes from a systematic review aiming to estimatethe effects of eight antithrombotic treatments including placeboin reducing the incidence of major thrombotic events in patientswith non-valvular atrial fibrillation (Dogliotti et al., 2014).The review included 20 studies with 79,808 participants, fourstudies are three-arm studies. The primary outcome is strokereduction (yes / no)."],"concepts":["medicine"," odds ratios"," network meta-analysis"," Mantel-Haenszelmethod"],"note":["Strictly speaking, there are only 31 trials, since Breddin et al.(1980) and ATACS (1990) are multiarm trials.According to a correction, ‘dat.anand1999$ci[29]’ should be 1. Butthen ‘dat.anand1999$ci[21]’ would also have to be 1 (if these dataindeed refer to the same control group). This appearscontradictory, so this correction was not made."],"source":["Dogliotti, A., Paolasso, E., & Giugliano, R. P. (2014). Currentand new oral antithrombotics in non-valvular atrial fibrillation:A network meta-analysis of 79808 patients. _Heart_, *100*(5),396-405. https://doi.org/10.1136/heartjnl-2013-304347See Also:‘pairwise’, ‘metabin’, ‘netmeta’, ‘netmetabin’"],"references":["NaN"]}